NorthStar Anesthesia Names Jeremiah Radandt as Chief Financial Officer

PR Newswire Association LLC

DALLAS, Aug. 18, 2014 /PRNewswire/ -- NorthStar Anesthesia has appointed Jeremiah Radandt chief financial officer.

Radandt brings significant health care leadership experience to his new role. In his most recent position, he served as chief financial officer for Primary Children's Hospital, a unit of Intermountain Healthcare that ranked in eight separate categories in U.S.News & World Report's Best Children's Hospitals for 2014. Prior to Intermountain he served as the vice president of strategy and chief financial officer for a key business unit of HealthMarkets, Inc., a leading national health insurance provider. Radandt also spent several years as a consultant with Bain & Company.

"Jeremiah's deep experience with physicians, hospitals, and insurance providers is a perfect fit for NorthStar Anesthesia as we continue to expand and grow," said NorthStar CEO Chris Riopelle. "His combination of management experience in respected health care companies and his consulting background equip him to contribute immediately as a member of our executive team."

Radandt earned an MBA in health care management from The Wharton School at the University of Pennsylvania. Radandt also holds an undergraduate degree from Brigham Young University.

About NorthStar Anesthesia

NorthStar Anesthesia is a company of caregivers, founded by an anesthesiologist and a CRNA. NorthStar partners with hospitals and ASCs to deliver a more productive and efficient model of anesthesia care. Its care team approach focuses on the provision of high quality while measurably improving operating room performance. That same approach attracted a majority investment from TPG Growth in 2013 and established NorthStar as one of the most successful and fastest growing anesthesia care companies in America. For more information, visit www.northstaranesthesia.com.

About TPG Growth

TPG Growth is the middle market and growth equity investment platform of TPG, the global private investment firm. With $3.7 billion under management, TPG Growth targets investments in a broad range of industries and geographies. The firm is backed by the resources of TPG, which has over $59 billion of assets under management. TPG has a long history of investments in healthcare including Par Pharmaceutical Companies, Biomet, Evolent Health, IASIS Healthcare, Healthscope Limited, Sutures India Pvt Ltd, Surgical Care Affiliates, IMS Health, Access Clinical Partners, Biomet, Envision Pharmaceutical, Quintiles Transnational, Oxford Health Plans and IMDSoft, among others. TPG Growth has offices in the United States, China and India. For more information, visit www.tpggrowth.com.